UK Disabilities (PIP) Project

PIP Clearances project brief (pdf)

Layout of the UK disability analysis

The analysis of disabilities in the UK is based on investigation of the Personal Independence Pension (PIP) program by the Department of Work and Pensions (DWP) in the UK. The data is monthly and provides a level of granularity that allows different studies to be performed, such as analysis by age group, sex, and underlying cause for the claim. We are currently working on the different aspects of the data analysis which will be rolled out on our website as it is completed.

UK Personal Independence Payments report. Go to PIP Analysis
This report outlines the monthly patterns in disability payments throughout the COVID-19 pandemic. We show that a substantial increase in PIP applications and new PIP entitlements occurred shortly after the beginning of 2021 which cannot be explained by changes in the size of the working-age population, nor by a decrease in the percentage of PIP applications that are rejected.

Analysis of PIP Clearances (New Claims) by Body System (associated to the underlying cause for the claim). Go to PIP - Body Systems
This part provides an examination of the changes in disabilities in the UK (PIP claims) by the different body system classification that are associated to the underlying cause for the claim.

Analysis of PIP Clearances (New Claims) by Underlying Cause. Go to PIP - Underlying Causes
This part provides an examination of the changes in disabilities in the UK (PIP claims) by underlying cause and for different population age groups.

Review of Korean population-based papers that corroborate the PIP analysis. Go to paper review
We review 3 population-based studies from South Korea that show a relationship between the Covid-19 vaccinations and subsequent diverse non-fatal adverse events. The main author for the three papers is Eun Mi Chun, who, with access to the population dataset analysed incidence rates of different non-fatal health conditions from the date of the Covid-19 innoculation. The authors compare the incidence rates for the different conditions in vaccinanted versus un-vaccinated individuals, up to 12 weeks prior the innoculation date. The results were published in three different papers as they investigated different types of adverse events.